Gail Naughton, Director at CR Bard, holds 0.00 shares in TherapeuticsMD (Ticker: TXMD), holds 426.53K shares in Histogen (Ticker: HSTO), holds 0.00 shares in CR Bard (Ticker: BCR). Most recently, Gail Naughton Sold ― shares of TherapeuticsMD on Dec 08, 2022 for an estimated value of 20.63K.